Chapter 89

Reference

  1. Acharya SK. 1999. Management of hepatocellular carcinoma: many ways to skin a cat. Trop Gastroenterol 20:59-60.
  2. Allen L, Stobie D, Mauldin N, et al. 1999. Clinicopathologic features of dogs with hepatic microvascular dysplasia with and without portosystemic shunts:42 cases (1991–1996). J Am Vet Med Assoc 214:218-220.
  3. Amacher DE, Martin BA. 1997. Tetracycline-induced steatosis in primary canine hepatocyte cultures. Fundam Appl Toxicol 40:256-263.
  4. American Society of Hospital Pharmacists. 1996. APHIS formulary. American Hospital Formulary Service, Bethesda, MD.
  5. American Society of Hospital Pharmacists. 2010. APHIS formulary. American Hospital Formulary Service, Bethesda, MD.
  6. Angulo P. 2002. Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231.
  7. Armstrong JA, Taylor SM, Tryon KA, et al. 2000. Emphysematous cholecystitis in a Siberian husky. Can Vet J 41:60-62.
  8. Bacon NJ, White RA. 2003. Extrahepatic biliary tract surgery in the cat: a case series and review. J Small Anim Pract 44:231-235.
  9. Bae WK, Moon YS, Kim JH, et al. 2008. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol 51:248-254.
  10. Bahador M, Cross AS. 2007. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J Endotoxin Res 13:251-279.
  11. Bajaj JS, Saeian K, Christensen KM, et al. 2008. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 103:1707-1715.
  12. Barnhart MD, Rasmussen LM. 1996. Pleural effusion as a complication of extra hepatic biliary tract rupture in a dog. J Am Anim Hosp Assoc 32:409-412.
  13. Bass NM, Mullen KD, Sanyal A, et al. 2010. Rifaximin treatment in hepatic encephaloopathy. N Engl J Med 25:1071-1081.
  14. Bass NM, Williams RL. 1990. Hepatic function and pharmacokinetics, pp 235-254. In Zakim D, Boyer TD (eds): Hepatology: a textbook of liver disease. WB Saunders, Philadelphia.
  15. Bauer TM, Steinbruckner B, Brinkmann FE, et al. 2001. Small intestinal bacteriial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 96:2962-2967.
  16. Besso JG, Wrigley RH, Gliatto JM, et al. 2000. Ultrasonographic appearance and clinical findings in 14 dogs with gallbladder mucocele. Vet Radiol Ultrasound 41:261-271.
  17. Bigatello LM, Broitman SA, Fattori L, et al. 1987. Endotoxemia without out sepsis is a common finding in humans with cirrhosis and increased levels are associated with hepatic failure, hepatic encephalopathy, and death. Am J Gastroenterol 82:11-15.
  18. Bilzer M, Roggel F, Gerbes AL. 2006. Role of Kupffer cells in host defense and liver disease. Liver Int 26:1175-1186.
  19. Birnbaum N, Barr SC, Center SA, et al. 1998. Naturally acquired leptospirosis in 36 dogs: serological and clinicopathological features. J Small Anim Pract 39:231-236.
  20. Bishop L, Strandberg JD, Adams RJ, et al. 1979. Chronic active hepatitis in dogs associated with leptospires. Am J Vet Res 40:839-844.
  21. Bogdanos D-P, Koutsoumpas A, Baum H, et al. 2006. Borrelia burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis. Dig Liver Dis 38:781-785.
  22. Boisclair J, Doré M, Beauchamp G, et al. 2001. Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet Pathol 38:628-635.
  23. Boomkens SY, Kusters JG, Hoffmann G, et al. Detection of Helicobacter pylori in bile of cats. FEMS Immunol Med Microbiol 2004;42:307-311.
  24. Bosje JT, van den Ingh TS, Fennema A, et al. 2003. Copper-induced hepatitis in an Anatolian shepherd dog. Vet Rec 152:84-85.
  25. Branum GD, Tyson GS, Branum MA, et al. 1990. Hepatic abscess: changes in etiology, diagnosis, and management. Ann Surg 212:655-662.
  26. Brown B, Mauldin GE, Armstrong J, et al. 2000. Metabolic and hormonal alterations in cats with hepatic lipidosis. J Vet Intern Med 14:20-26.
  27. Burk RL, Johnson GF. 1980. Emphysematous cholecystitis in the nondiabetic dog: three case histories. Vet Radiol 21:242-245.
  28. Cain JL, Labat JA, Cohn I. 1967. Bile peritonitis in germ-free dogs. Gastroenterology 53:600-603.
  29. Camussi G, Albano E, Tetta C, et al. 1991. The molecular action of tumor necrosis factor-alpha. Eur J Biochem 202:3-14.
  30. Cardoso V, Pimenta A, da Fonseca JC, et al. 1982. The effect of cholestasis on hepatic clearance of bacteria. World J Surg 6:330-334.
  31. Center SA. 1990. Hepatobiliary infections, pp 146-183. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  32. Center SA. 1996. Diseases of the gallbladder and biliary tree, pp 860-888. In Guilford G, Center SA, Strombeck D, et al. (eds): Strombeck's small animal gastroenterology, ed 3. WB Saunders, Philadelphia.
  33. Center SA. 1998. Hepatobiliary infections, pp 615-625. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  34. Center SA. 2005. Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 35:225-269.
  35. Center SA. 2011. Unpublished observations. Cornell University, Ithaca, NY.
  36. Center SA, Elston TH, Rowland PH, et al. 1996. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc 209:618-625.
  37. Center SA, Randolph JF, Warner KL, et al. 2005. The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats. J Vet Intern Med 2005;303-314.
  38. Center SA, Rowland PH. 1994. Cholangitis/cholangiohepatitis complex in the cat, pp 766-771. In Proceedings of the 12th ACVIM Forum, San Francisco.
  39. Center SA, Sunvold GD. 2000. Investigations of the effect of L-carnitine on weight reduction, body condition, and metabolism in obese dogs and cats, pp 113-122. In Reinhart GA, Carey DP (eds): Recent advances in canine and feline nutrition, vol III. Proceeding of the Iams Nutrition Symposium. Orange Frazer Press, Wilmington, OH.
  40. Center SA, Warner K, Corbett J, et al. 2000. Proteins invoked by vitamin K absence and clotting times in clinically ill cats. J Vet Intern Med 14:292-297.
  41. Center SA, Warner KL, Corbett JR. 1998. PIVKA clotting times in dogs with suspected coagulopathies. J Vet Intern Med 12:214.
  42. Center SA, Warner KL, Erb HN. 2002. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 63:1187-1197.
  43. Chanda S, Mehendale HM. 1996. Role of nutrition in the survival after hepatotoxic injury. Toxicology 111:163-178.
  44. Chang CS, Chen GH, Lien HC, et al. 1998. Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients and spontaneous bacterial peritonitis. Hepatology 28:1187-1190.
  45. Chapman BL, Hendrick MJ, Washabau RJ. 1993. Granulomatous hepatitis in dogs. Nine cases (1987–1990). J Am Vet Med Assoc 203:680-684.
  46. Chiva M, Soriano G, Rochat I, et al. 2002. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 37:456-462.
  47. Chrusch C, Bands C, Bose D, et al. 2000. Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis. Am J Respir Crit Care Med 161:517-526.
  48. Chuang JH, Chen WJ, Lo SK, et al. 1997. Adverse metabolic and microbiologic effects of tube feeding in experimental canine obstructive jaundice. J Parenter Enteral Nutr 21:36-40.
  49. Chuang JH, Shieh CS, Changh NK, et al. 1993. Role of the parenteral nutrition in preventing malnutrition and decreasing bacterial translocation to liver in obstructive jaundice. World J Surg 17:580-586.
  50. Chuang YH, Lan RY, Gershwin ME. 2009. The immunopathology of human biliary cell epithelium. Semin Immunopathol 31:323-331.
  51. Civardi G, Di Candio G, Giorgio A, et al. 1998. Ultrasound guided percutaneous drainage of abdominal abscesses in the hands of the clinician: a multicenter Italian study. Eur J Ultrasound 8:91-99.
  52. Clausen MR, Mortensen PB. 1997. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53:930-942.
  53. Cobb LM, McKay KA. 1962. A bacteriological study of the liver of the normal dog. J Comp Pathol 72:92-96.
  54. Cole TL, Center SA, Flood SN, et al. 2002. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc 220:1483-1490.
  55. Crocker SH, Eddy DO, Obenauf RN, et al. 1981. Host-specific lung clearance and pulmonary failure. J Trauma 21:215-220.
  56. Crosby HA, Bion JF, Penn CW, et al. 1994. Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 40:23-30.
  57. Dahlinger J, Marks SL, Hirsh DC. 1997. Prevalence and identity of translocating bacteria in healthy dogs. J Vet Int Med 11:319-322.
  58. Danon O, Duval-Arnould M, Osman Z, et al. 2000. Hepatic and splenic involvement in cat-scratch disease: imaging features. Abdom Imaging 25:182-183.
  59. Davis KM, Spaulding KA. 2004. Imaging diagnosis: biliopleural fistula in a dog. Vet Radiol Ultrasound 45:70-72.
  60. Deitch EA. 1992. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 216:117-134.
  61. Deitch EA, Berg R, Specian R. 1987. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 122:185-190.
  62. Deitch EA, McIntyre-Bridge R. 1987. Effect of stress and trauma on bacterial translocation from the gut. J Surg Res 42:536-542.
  63. Deitch EA, Sittig K, Li M, et al. 1990. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 15:979-984.
  64. Deitch EA, Wen-Jing MA, Berg R, et al. 1989. Endotoxin-induced bacterial translocation: a study of mechanisms. Surgery 106:292-299.
  65. Dineen P. 1978. The importance of the route of infection in experimental biliary tract obstruction. Surg Gynecol Obstet 119:1001-1008.
  66. Dirix LY, Polson RJ, Richardson A, et al. 1989. Primary sepsis presenting as fulminant hepatic failure. Q J Med 73:1037-1043.
  67. Dow SW, Jones RL. 1987. Anaerobic infections: part II. Diagnosis and treatment. Compend Contin Educ Pract Vet 9:827-839.
  68. Dumlar JS, Bakken JS. 1995. Ehrlichial diseases of humans: emerging tickborne infections. Clin Infect Dis 20:1102-1110.
  69. Dunne DW, Resnick D, Greenberg J, et al. 1994. The type 1 macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci USA 91:1863-1867.
  70. Eich CS, Ludwig LL. 2002. The surgical treatment of cholelithiasis in cats: a study of nine cases. J Am Anim Hosp Assoc 38:290-296.
  71. Faraj BA, Farouk M, Ali JT, et al. 1982. Hepatorenal failure induced by tetracycline in dogs with portacaval shunt. J Pharm Exp Ther 22:558-563.
  72. Farrar ET, Washabau RJ, Saunders HM. 1996. Hepatic abscesses in dogs: 14 cases (1982–1994). J Am Vet Med Assoc 208:243-247.
  73. Fiers W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212.
  74. Filkins JP, Cornell RP. 1974. Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxic shock. Am J Physiol 227:778.
  75. Forrester SD, Rogers KS, Relford RL. 1992. Cholangiohepatitis in a dog. J Am Vet Med Assoc 200:1704-1706.
  76. Fox ES, Thomas P, Broitman SA. 1987. Comparative studies of endotoxin uptake by isolated rat Kupffer and peritoneal cells. Infect Immunol 55:2962-2966.
  77. Fox JG, Dewhirst FE, Shen Z, et al. 1998. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:775-763.
  78. Fox JG, Drolet R, Higgins R, et al. 1996. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34:2479-2482.
  79. Freneaux E, Labbe G, Letteron P, et al. 1988. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 8:1056-1062.
  80. Funaoka M, Kornatsu M, Toyoshima I, et al. 1999. Tauroursodeoxycholic acid enhances phagocytosis of the cultured rat Kupffer cell. J Gastroenterol Hepatol 14:652-658.
  81. Gagne JM, Armstrong PJ, Weiss DJ, et al. 1999. Clinical features of inflammatory liver disease in cats: 41 cases (1983–1993). J Am Vet Med Assoc 214:513-516.
  82. Gagne JM, Weiss DJ, Armstrong PJ. 1996. Histopathologic evaluation of feline inflammatory liver disease. Vet Pathol 33:521-526.
  83. Galarneau JR, Fortin M, Lapointe JM, et al. 2003. Citrobacter freundii septicemia in two dogs. J Vet Diagn Invest 15:297-299.
  84. Gillespie TN, Washabau RJ, Goldschmidt MH, et al. 2003. Detection of Bartonella henselae and Bartonella clarridgeiae DNA in hepatic specimens from two dogs with hepatic disease. J Am Vet Med Assoc 222:47-51.
  85. Gocke DJ, Morris TQ, Bradley SE. 1970. Chronic hepatitis in the dog. The role of immune factors. J Am Vet Med Assoc 156:1700-1705.
  86. Goldstein RE, Lin RC, Langston CE, et al. 2006. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J Vet Intern Med 20:489-494.
  87. Gonciarz A, Trusz-Gluza M, Kusmierski S, et al. 1974. Leukocytic proteases in gallbladder pathology. Experimental acute cholecystitis in dogs. Digestion 10:65-72.
  88. Gores BR, Berg J, Carpenter JL, et al. 1994. Chylous ascites in cats: nine cases (1978–1993). J Am Vet Med Assoc 205:1161-1164.
  89. Gouma DJ, Coelho JCU, Fisher JD, et al. 1986. Endotoxemia after relief of biliary obstruction by internal and external drainage in rats. Am J Surg 51:476-479.
  90. Gratz SW, Mykkanen H, El-Nezami HS. 2010. Probiotics and gut health: a special focus on liver diseases. World J Gastroentrol 16:403-410.
  91. Greenway CV, Lautt WW. 1970. Effects of hepatic venous pressure on fluid transfer in the liver of the anesthetized cat. Circ Res 26:697-703.
  92. Gregory SH, Sagnimeni AJ, Wing EJ. 1996. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 157:2514-2520.
  93. Gregory SH, Wing EJ. 2002. Neutrophil-Kupffer cell interaction: a critical component of host defense to systemic bacterial infections. J Leukoc Biol 72:239-248.
  94. Greir A, Fickert P, Trauner M. 2006. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3:574-585.
  95. Greiter-Wilke A, Scanziani E, McDonogh, et al. 2006. Association of Helicobacter with cholangiohepatitis in cats. J Vet Intern Med 20:822-827.
  96. Griffiths J, Groves AC, Leung FY. 1973. Hypertriglyceridemia and hypoglycemia in gram-negative sepsis in the dog. Surg Gynecol Obstet 136:897.
  97. Groner JL, Edmiston CE Jr, Krepel CJ, et al. 1989. The efficacy of oral antimicrobials in reducing aerobic and anaerobic colonic mucosal flora. Arch Surg 124:281-284.
  98. Grooters AM, Sherding RG, Biller S, et al. 1994. Hepatic abscesses associated with diabetes mellitus in two dogs. J Vet Intern Med 8:203-206.
  99. Groves AC, Woolf LI, O’Regan PJ, et al. 1974. Impaired gluconeogenesis in dogs with E. coli bacteremia. Surgery 76:533-538.
  100. Gustot T, Durand F, Lebrec D, et al. 2009. Severe sepsis in cirrhosis. Hepatology 50:2022-2033.
  101. Harada K, Isse K, Nakanuma Y. 2006. Interferon gamma accelerates NF-κB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 59:184-190.
  102. Hargis AM, Thomassen RW. 1980. Hepatic abscesses in beagle puppies. Lab Anim Sci 30:689-693.
  103. Harkin KR, Gartrell CL. 1996. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990–1995). J Am Anim Hosp Assoc 32:495-501.
  104. Hazrah P, Oahn KTH, Tewari M, et al. 2004. The frequency of live bacteria in gallstones. HPB (Oxford) 6:28-32.
  105. Heller J, Sogni P, Barrieve E, et al. 2000. Effects of lipopolysaccharide on TNF-α production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 33:376-381.
  106. Hornof WJ, Koblick PD, Breznock EM. 1983. Radiocolloid scintigraphy as an aid to the diagnosis of congenital portocaval anomalies in the dog. J Am Vet Med Assoc 182:44-46.
  107. Horowitz HW, Dworkin B, Forseter G, et al. 1996. Liver function in early Lyme disease. Hepatology 23:1412-1417.
  108. Howe LM, Boothe DM, Boothe HW. 1997. Endotoxemia associated with experimentally induced multiple portosystemic shunts in dogs. Am J Vet Res 58:83-88.
  109. Hu LT, Klempner MS. 1997. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol 17:354-365.
  110. Ishikawa M, Miyauchi T, Yagi K, et al. 1999. Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection. World J Surg 23:75-79.
  111. Ito K, Ito S, Naito A, et al. 1988. Ultrasonographic manifestations of liver abscesses: an experimental study, Hiroshima. J Med Sci 37:63-69.
  112. Jackson JJ, Kropp H. 1992. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 165:1033-1041.
  113. Jackson MW, Panciera DL, Hartmann F. 1994. Administration of vancomycin for treatment of ascending bacterial cholangiohepatitis in a cat. J Am Vet Med Assoc 204:602-605.
  114. Jones EA, Summerfield JA. 1988. Kupffer cells, pp 683-704. In Arias IM, Jakoby WB, Popper H, et al. (eds): The liver: biology and pathobiology, ed 1. Raven Press, New York.
  115. Kantek CE, Kociba GJ, Kowalski JJ. 1981. Serum biochemical changes in dogs with experimental Leptospira interrogans serovar Icterohaemorrhagiae infection. Am J Vet Res 42:1125-1129.
  116. Kaufman AC. 1994. Infectious causes of feline hepatobiliary disease. Vet Med 89:869-873.
  117. Kaufmann JE, Vischer UM. 2003. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 1:682-689.
  118. Kawarabayashi N, Seki S, Hatsuse, et al. 2010. Immunosuprression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis. Shock 33:500-506.
  119. Kazakoff MA, Sinusas K, Macchia C. 1993. Liver function tests abnormalities in early Lyme disease. Arch Fam Med 2:409-413.
  120. Keane RM, Collins PB, Hohnson AN, et al. 1986. Delayed homograft rejection following common bile duct ligation: in vivo evidence that obstructive jaundice is immunosuppressive. Ir J Med Sci 155:143-146.
  121. Keenan KP, Alexander AD, Montgomery CA. 1978. Pathogenesis of experimental Leptospira interrogans, serovars bataviae, infection in the dog: microbiological, clinical, hematological, and biochemical studies. Am J Vet Res 39:449-454.
  122. Keighley MRB, Drysdale RB, Quoraishi AH, et al. 1976. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut 17:495-500.
  123. Kelly DA, Summerfield JA. 1987. Hemostasis in liver disease. Semin Liver Dis 7:182-191.
  124. Kirpensteijn J, Fingland RB, Ulrich T, et al. 1993. Cholelithiasis in dogs: 29 cases. J Am Vet Med Assoc 202:1137-1142.
  125. Kitchell BE, Fan TM, Wallenberg G, et al. 2000. Peliosis hepatis in a dog infected with Bartonella henselae. J Am Vet Med Assoc 216:519-523.
  126. Klatchko BA, Schwartz SI. 1989. Diagnostic and therapeutic approaches to pyogenic abscess of the liver. Surg Gynecol Obstet 168:332-336.
  127. Koblik PD, Hornof WS, Yen CK, et al. 1995. Use of technetium-99 m sulfur colloid to evaluate changes in reticuloendothelial function in dogs with experimentally induced chronic biliary cirrhosis and portosystemic shunting. Am J Vet Res 56:688-693.
  128. Konno K, Ishida H, Naganuma H, et al. 2002. Emphysematous cholecystitis: sonographic findings. Abdom Imaging 27:191-195.
  129. Kordick DL, Brown TT, Shin K, et al. 1999. Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats. J Clin Microbiol 37:1536-1547.
  130. Kosters A, Karpen SJ. 2010. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liv Dis 30:186-194.
  131. Krishnamurthy S, Krishnamurthy GT. 1989. Technetium-99 m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology 9:139-153.
  132. Lapointe JM, Higgins R, Barrette N, et al. 2000. Enterococcus hirae enteropathy with ascending cholangitis and pancreatitis in a kitten. Vet Pathol 37:282-284.
  133. Laskin DL, Weinberger B, Laskin JD. 2001. Functional heterogeneity in liver and lung macrophages. J Leuko Biol 70:163-170.
  134. Lee WY, Moriarty TJ, Wong CHY, et al. 2010. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 11:295-303.
  135. Legendre AM, Krahwinkel DJ, Carrig CB, et al. 1976. Ascites associated with intrahepatic arteriovenous fistula in a cat. J Am Vet Med Assoc 168:589-591.
  136. Leong RWL, Sung JJY. 2002. Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16:1037-1045.
  137. Lepage G, Paradis K, Lacaille F, et al. 1997. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis. J Pediatr 130:52-58.
  138. Lepper PM, Held TK, Schneider EM, et al. 2002. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 28:824-833.
  139. Leung JW, Ling TK, Chan RC, et al. 1994. Antibiotics, biliary sepsis and bile duct stones. Gastrointest Endosc 40:716-721.
  140. Liehr H, Englisch G, Rasenack U. 1980. Lactulose, a drug with antiendotoxin effect. Hepatogastroenterology 27:356-360.
  141. Liu Q, Duan ZP, Ha DK, et al. 2004. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441-1449.
  142. Lord PF, Carb A, Halliwell WH, et al. 1982. Emphysematous hepatic abscess associated with trauma, necrotic nodular hyperplasia and adenoma in a dog: a case history report. Vet Radiol 23:46-49.
  143. Lord PF, Wilkins RJ. 1972. Emphysema of the gallbladder in a diabetic dog. J Am Vet Radio Soc 13:49-52.
  144. Lygidakis NJ, Van der Heyde MN, Lubbers MJ. 1987. Evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chir Scand 153:665-668.
  145. Lykkegaard NM, Asnaes S, Justesen T. 1976. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction: III. Possible synergistic effect between anaerobic and aerobic bacteria. Scand J Gastroenterol 11:263-272.
  146. Macintire DK, Henderson RH, Banfield C, et al. 1995. Budd-Chiari syndrome in a kitten, caused by membranous obstruction of the caudal vena cava. J Am Anim Hosp Assoc 31:484-491.
  147. Mack DR, Michail S, Wei S, et al. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941-G950.
  148. Malaguarnera M, Greco F, Barone G, et al. 2007. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized double-blind, placebo-controlled study. Dig Dis Sci 52:3259-3265.
  149. Mannucci PM. 1997. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90:2515-2521.
  150. Martin RA, Walsh KM, Zimmer JF, et al. 1985. Effects of intestinal reflux into the hepatobiliary ducts following biliary enteric anastomosis in the dog. Vet Surg 14:59-60.
  151. Mayhew PD, Holt DE, McLear RC, et al. 2002. Pathogenesis and outcome of extrahepatic biliary obstruction in cats. J Small Anim Pract 43:247-253.
  152. Mayhew PD, Weisse CW. 2008. Treatment of pancreatitis-associated extrahepatic biliary tract obstruction by choledochal stenting in seven cats. J Small Anim Pract 49:133-138.
  153. McDonald MI, Corey GR, Gallis HA, et al. 1984. Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment with percutaneous drainage. Medicine 63:291-302.
  154. McGrotty YL. 2001. What is your diagnosis? Cirrhosis. J Small Anim Pract 42:477, 517.
  155. Mealey KL, Minch JD, White SN, et al. 2010. An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs. Comp Hepatol 9:6.
  156. Men S, Akhan O, Koroglu M. 2002. Percutaneous drainage of abdominal abscess. Eur J Radiol 43:204-218.
  157. Mendler MH, Turlin B, Moirand R, et al. 1999. Insulin resistance-associated hepatic iron overload. Gastroenterology 117:1155-1163.
  158. Miller DJ, Keeton GR, Webber BL, et al. 1976. Jaundice in severe bacterial infection. Gastroenterology 71:94-97.
  159. Moore SW, Millar AJ, Cywes S. 1994. Conservative initial treatment of liver abscess in children. Br J Surg 81:872-874.
  160. Moskovitz M, Fadden R, Min T. 1991. Human ehrlichiosis: a rickettsial diseases associated with severe cholestasis and multisystemic disease. J Clin Gastroenterol 13:86-90.
  161. Mulder J, Karpen SJ, Tietge UJ, et al. 2009. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis. Front Biosci 14:2599-2630.
  162. Newell SM, Graham JP, Roberts GD, et al. 2001. Quantitative hepatobiliary scintigraphy in normal cats and in cats with experimental cholangiohepatitis. Vet Radiol Ultrasound 42:70-76.
  163. Niehaus GD, Schumacker PR, Saba TM. 1980. Reticuloendothelial clearance of blood-borne particulates. Ann Surg 191:479-487.
  164. Nilsson HO, Taneera J, Castedel M, et al. 2000. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 38:1072-1076.
  165. Niza MMRE, Ferreira AJA, Peleteiro MC, et al. 2004. Bacteriologic study of the liver in dogs. J Small Anim Pract 45:401-404.
  166. Nolan JP. 1975. The role of endotoxin in liver injury. Gastroenterology 69:1346-1356.
  167. Nolan JP. 1978. Bacteria and the liver. N Engl J Med 299:1069-1070.
  168. Nora PF, Bransfield JJ, Laufman H. 1969. Hyperbaria in experimental bile peritonitis. Arch Surg 98:235-238.
  169. Nyland TG, Gillett NA. 1982. Sonographic evaluation of experimental bile duct ligation in the dog. Vet Radiol 13:252-260.
  170. O'Dwyer ST, Michie HR, Ziegler TR, et al. 1988. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123:1459-1464.
  171. Ohta T, Nakagawa T, Ueda N, et al. 1991. Adenomatous hyperplasia of the bile duct epithelium of the canine liver, caused by bacterial infection. Scand J Gastroenterol 26:1107-1114.
  172. O’Neill EJ, Day MJ, Hall EJ, et al: Bacterial cholangitis/cholangiohepatitis with or without concurrent cholecystitis in four dogs. J Small Anim Pract 2006;47:325-335.
  173. Owens SD, Gossett R, McElhaney MR, et al. 2003. Three cases of canine bile peritonitis with mucinous material in abdominal fluid as the prominent cytologic finding. Vet Clin Pathol 32:114-120.
  174. Pain JA. 1987. Reticulo-endothelial function in obstructive jaundice. Br J Surg 74:1091-1094.
  175. Pappalardo BL, Brown TT, Tompkins M, et al. 2001. Immunopathology of Bartonella vinsonii (berkhoffii) in experimentally infected dogs. Vet Immunol Immunopathol 83:125-147.
  176. Pardo A, Bartoli R, Lorenzo-Zuniga V, et al. 2000. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 31:858-863.
  177. Pearson AM. 1996. Scavenger receptors in innate immunity. Curr Opin Immunol 8:20-28.
  178. Pelligrini CA, Allegra P, Bongard FS, et al. 1987. Risk of biliary surgery in patients with hyperbilirubinemia. Am J Surg 154:111-117.
  179. Pereg D, Kotliroff A, Gadoth N, et al. 2011. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 27:177-181.
  180. Perez-del-Pulgar S, Pizcueta P, Engel P, et al. 2001. Neutrophil adhesion is impaired in the mesentery but not in liver sinusoids of portal hypertensive rats. Am J Physiol Gastrointest Liver Physiol 280:G1351-G1359.
  181. Perez-Paramo M, Munoz J, Albillos A, et al. 2000. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 31:43-48.
  182. Peterson SL, Koblik PD, Whiting PG, et al. 1991. Endotoxin concentrations measured by a chromogenic assay in portal and peripheral venous blood in ten dogs with portosystemic shunts. J Vet Intern Med 5:71-74.
  183. Rautio M, Jousimies-Somer H, Kauma H, et al. 1999. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28:1159-1160.
  184. Rentko VT, Clark N, Ross LA, et al. 1992. Canine leptospirosis: a retrospective of 17 cases. J Vet Intern Med 6:235-244.
  185. Rerknimitr R, Fogel EL, Kalayci C, et al. 2002. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 56:885-889.
  186. Reynolds JV, Murchan P, Leonard N. 1996. Gut barrier failure in experimental obstructive jaundice. J Surg Res 62:11-16.
  187. Reynolds JV, Murchan P, Redmond HP, et al. 1995. Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg 82:534-538.
  188. Rimola A, Soto R, Bory F, et al. 1984. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4:53-58.
  189. Robenek H, Herwig J, Themann H. 1980. The morphologic characteristics of the intracellular junctions between normal human liver cells and dells from patients with extrahepatic cholestasis. Am J Pathol 100:93-114.
  190. Rolachon A, Cordier L, Bacq Y, et al. 1995. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 22:1171-1174.
  191. Roughneen PT, Drath DB, Kulkarni AD, et al. 1987. Impaired non-specific cellular immunity in experimental cholestasis. Ann Surg 206:578-582.
  192. Sakaguchi S, Furusawa S. 2006. Oxidative stress and septic shock: metabolic aspects to oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 47:167-177.
  193. Salix Pharmaceuticals. 2008. Xifaxan (rifaximin) tablets [Prescribing information]. Palo Alto, CA.
  194. Sambri V, Aldinin R, Massaria F, et al. 1996. Uptake and killing of Lyme disease and relapsing fever Borreliae in the perfused rat liver and by isolated Kupffer cells. Infect Immun 64:1858-1861.
  195. Sanford JP, Gilbert DN, Gerberding JL, et al. 1995. The Sanford guide to antimicrobial therapy. Antimicrobial Therapy, Dallas.
  196. Sanford JP, Moellering RC, Sande MA. 2010. The Sanford guide to antimicrobial therapy. Antimicrobial Therapy Inc., Hyde Park, VT.
  197. Santos AA, Wilmore DW. 1996. The systemic inflammatory response: perspective of human endotoxemia. Shock 6:S50-S56.
  198. Savary-Bataille KC, Bunch SE, Spaulding KA, et al. 2003. Percutaneous ultrasound-guided cholecystocentesis in healthy cats. J Vet Intern Med 17:298-303.
  199. Saxelin M, Chuang NH, Chassy B, et al. 1996. Lactobacilli and bacteremia in southern Finland 1989–1992. Clin Infect Dis 22:565-566.
  200. Scevola D, Magliulo E, Trpin L, et al. 1979. Control of endotoxemia in liver disease by lactulose and paromomycin. Boll Ist Sieroter Milan 58:242-247.
  201. Schimple G, Pesendorfer P, Steinwender G, et al. 1996. Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats. Gut 39:48-53.
  202. Schimple G, Pesendorfer P, Steinwender G, et al. 1997. The effect of vitamin C and vitamin E supplementation on bacterial translocation in chronic portal hypertensive and common-bile-duct ligated rats. Eur Surg Res 29:187-194.
  203. Schumann J, Angermuller S, Banhg R, et al. 1998. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 161:5745-5754.
  204. Schwarz LA, Penninck DG, Leveille-Webster C. 1998. Hepatic abscesses in 13 dogs: a review of the ultrasonographic findings, clinical data, and therapeutic options. Vet Radiol Ultrasound 39:357-365.
  205. Scott AJ, Khan GA. 1967. Origin of bacteria in bile duct bile. Lancet 2:790-792.
  206. Scott-Conner DEH, Grogan JB. 1994. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 57:316-336.
  207. Sewnath ME, Karsten TM, Prins MH, et al. 2002. A metaanalysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236:17-27.
  208. Sharma M, Briski LE, Khatib R. 2002. Hepatic actinomycosis: an overview of salient features and outcome of therapy. Scand J Infect Dis 34:386-391.
  209. Slocum MM, Sittig KM, Specian RD, et al. 1992. Absence of intestinal bile promotes bacterial translocation. Am Surg 58:305-310.
  210. Speeti M, Eriksson J, Saari S, et al. 1998. Lesions of subclinical Doberman hepatitis. Vet Pathol 35:361-369.
  211. Stephenson S, Nagel C. 1963. Acute cholecystitis. An experimental study. Ann Surg 157:687-694.
  212. Sterczer A, Gaál T, Perge E, et al. 2001. Chronic hepatitis in the dog—a review. Vet Q 23:148-152.
  213. Styrt B, Gorbach SL. 1989. Recent developments in the understanding of the pathogenesis and treatment of anaerobic infections: part I. N Engl J Med 321:240-246.
  214. Styrt B, Gorbach SL. 1989. Recent developments in the understanding of the pathogenesis and treatment of anaerobic infections: part II. N Engl J Med 321:298-302.
  215. Su GL. 2002. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283:G256-G265.
  216. Subhani DJ, Hamilton-Miller JMT, Brumfitt W, et al. 1984. Antibiotics in the treatment of biliary infection. Gut 25:988-998.
  217. Subhani JM, Kibbler C, Dooley JS. 1999. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCPP). Aliment Pharmacol Ther 13:103-116.
  218. Sung JY, Chung SC, Leung JCK, et al. 1994. Biliary IgA secretion in obstructive jaundice: the effects of endoscopic drainage. Gastrointest Endosc 40(Suppl):127-144.
  219. Sung JY, Leung JW, Shaffer EA, et al. 1992. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 7:240-245.
  220. Sung JY, Shaffer EA, Costerton JW. 1993. Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and the presence of phospholipids. Dig Dis Sci 38:2104-2112.
  221. Sung JY, Shaffer EA, Olson ME, et al. 1991. Bacterial invasion of the biliary system by way of the portal-venous system. Hepatology 14:313-317.
  222. Suzuki K, Nakayama H, Doi K. 2001. Giant cell hepatitis in two young cats. J Vet Med Sci 63:199-201.
  223. Swalec-Tobias KM, Besser TE. 1997. Evaluation of leukocytosis, bacteremia, and portal vein partial oxygen tension in clinically normal dogs and dogs with portosystemic shunts. J Am Vet Med Assoc 211:715-718.
  224. Tabata M, Nakayama F. 1984. Bacteriology of hepatolithiasis. Prog Clin Biol Res 152:163-174.
  225. Taboada J, Meyer DJ. 1989. Cholestasis associated with extrahepatic biliary bacterial infection in five dogs. J Vet Intern Med 3:216-221.
  226. Thompson RLE, Hoper M, Diamond T, et al. 1990. Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg 77:1229-1232.
  227. Thornburg LP. 2000. A perspective on copper and liver disease in the dog. J Vet Diagn Invest 12:101-110.
  228. Tomioka M, Iinuma H, Okinaga K. 2000. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 92:276-282.
  229. Toshach K, Jackson MW, Dubielzig RR. 1997. Hepatocellular necrosis associated with subcutaneous injection of an intranasal Bordetella bronchiseptica-canine parainfluenza vaccine. J Am Anim Hosp Assoc 1997:33:126-128.
  230. Trede M, Schwall G. 1988. The complications of pancreatectomy. Ann Surg 207:39-47.
  231. Touhy KM, Rouzand GCM, Bruck WM, et al. 2005. Modulation of the human gut microflora towards improved health using prebiotics—assessment of efficacy. Curr Pharm Des 11:75-90.
  232. Trauner M, Fickert P, Stauber RE. 1999. Inflammation-induced cholestasis. J Gastroenterol Hepatol 14:946-959.
  233. Trauner M, Wagner M, Fickert P, et al. 2005. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39(Suppl 2):S111-S124.
  234. van der Gaag NA, Rauws EAJ, van Eijck CHJ, et al. 2010. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129-137.
  235. Vassalli P. 1992. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452.
  236. Verbanck J, Ponette J, Verbanck M, et al. 1999. Sonographic detection of multiple Staphylococcus aureus hepatic microabscesses mimicking Candida abscesses. J Clin Ultrasound 27:478-481.
  237. Victor VM, Rocha M, De la Fuente M. 2004. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmcol 4:327-347.
  238. Vörös K, Sterczer A, Manczur F, et al. 2002. Percutaneous ultrasound-guided cholecystocentesis in dogs. Acta Vet Hung 50:385-393.
  239. Wagner KA, Hartmann FA, Trepanier LA. 2007. Bacterial culture results from liver, gallbladder, or bile in 248 dogs and cats evaluated for hepatobiliary disease: 1998–2003. J Vet Intern Med 21:417-424.
  240. Wagner M, Zollner G, Trauner M. 2009. New molecular insights into the mechanisms of cholestasis. J Hepatol 51:565-580.
  241. Walker DH, Lesesne HR, Varma VA, et al. 1985. Rocky Mountain spotted fever mimicking acute cholecystitis. Arch Intern Med 145:2194-2196.
  242. Wang Q, Gurusamy KS, Lin H, et al. 2008. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev 3:CD005444.
  243. Warren AE, Center SA, McDonough SP, et al. 2011. Histopathologic features, immunophenotyping, clonality and eubacterial fluorescence in situ hybridization in cats with lymphocytic cholangitis/cholangiohepatitis. Vet Pathol 48:627-641.
  244. Watson PJ. 2004. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J 167:228-241.
  245. Westphal JF, Brogard J-M. 1999. Biliary tract infections: a guide to drug treatment. Drugs 57:81-91.
  246. Winkler GC. 1988. Pulmonary intravascular macrophages in domestic animal species. review of structural and functional properties. Am J Anat 181:217-234.
  247. Wozniak EJ, Barr BC, Thomford JW, et al. 1997. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris). J Parasitol 83:692-699.
  248. Yanaura S, Ishikawa S. 1978. Choleretic properties of ursodeoxycholic acid and chenodeoxycholic acid in dogs. Jpn J Pharmacol 28:383-389.
  249. Zaidi SA, Singer C. 2002. Gastrointestinal and hepatic manifestations of tickborne diseases in the United States. Clin Infect Dis 34:1206-1212.
  250. Zatelli A, Bonfanti U, Zini E, et al. 2005. Percutaneous drainage and alcoholization of hepatic abscesses in five dogs and a cat. J Am Anim Hosp Assoc 41:34-38.
  251. Zeman RK, Raylor KJW, Rosenfield AT, et al. 1981. Acute experimental biliary obstruction in the dog: sonographic findings and clinical implications. Am J Radiol 136:965-967.
  252. Zeuzem S. 2000. Gut liver axis. Int J Colorectal Dis 15:59-82.